Search for: "C Lillie"
Results 261 - 280
of 444
Sorted by Relevance
|
Sort by Date
6 Jul 2010, 6:03 pm
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
31 Mar 2009, 7:42 pm
Eli Lilly & Co., 265 U.S. 526, 528 (1928) Cf. [read post]
2 Oct 2009, 6:10 am
In an interview given to C-SPAN for their upcoming Supreme Court documentary, Scalia said "I mean lawyers, after all, don't produce anything. [read post]
27 Apr 2010, 10:58 pm
(The SPC Blog) EU: Originator drug companies hit by European ruling: C-62/09 Association of the British Pharmaceutical Industry (Managing Intellectual Property) EU: EPO – Convention on Biological Diversity and the exception to patentability for inventions which are contrary to ‘ordre public’ or morality (EPLAW) India: Patent office releases details on pharmaceutical product patents granted in last 3 years (Generic Pharmaceuticals and IP) (Spicy IP) Kenya: High Court… [read post]
6 Sep 2012, 9:17 am
According to their website, the bid values ShangPharma, with Eli Lilly and GlaxoSmithKline (www.gsk.com) among its clients, at between $157.5 million and $176 million. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
4 Feb 2019, 2:01 am
The new year sees the issue of yet another UK court case applying the doctrine of equivalents as established by the UK Supreme Court in Actavis v Eli Lilly ([2017] UKSC 48) ("Actavis"). [read post]
7 Dec 2014, 3:29 pm
As he explains in this post, this deeply detailed but well indexed–case that one of the IPKat’s favourite judges delivered last week deals with a patent in the technical field of Hepatitis C treatment. [read post]
31 Jan 2011, 8:10 am
Eli Lilly, just to name a few. [read post]
31 Jan 2011, 8:10 am
Eli Lilly, just to name a few. [read post]
11 Jun 2019, 3:48 am
Dáire McCormack-GeorgeIntroduction This blog constitutes the third instalment in a series of blogs about the nature of work and the purpose of labour regulation, with a specific focus on work in the EU. [read post]
9 Mar 2020, 1:21 pm
Humira: 5 biosimilars approved, none on the market; some will be entering, but only b/c of patent settlement agreements. 11 years earlier than otherwise might be possible. [read post]
25 Jun 2011, 4:55 am
Lewis & Art C. [read post]
1 Apr 2024, 6:48 pm
G. 2d [cited today as the Mutiny Act 1758, 32 Geo. 2 c. 5]. [read post]
27 Aug 2011, 7:55 pm
P. 56(c). [read post]
31 Jan 2007, 9:51 am
State of Indiana (NFP) Frank C. [read post]
9 Mar 2020, 3:19 pm
72(1)(c) of the Patents Act 1977. [read post]
2 Oct 2023, 7:23 am
Dom Kelly is the Co-Founder, President & CEO of New Disabled South, a 501(c)(3) nonprofit organization, and New Disabled South Rising, its 501(c)(4) arm.The post Building a Disability Organization Rooted in Disability Justice first appeared on Bill of Health.The post Building a Disability Organization Rooted in Disability Justice appeared first on Bill of Health. [read post]
27 Jul 2011, 1:01 am
General Decision for WIPO GA 49: Matters concerning the IGC on IP and genetic resources, traditional knowledge and folklore (KEI) (IP Watch) (IP Watch) Corporate self-interest and strategic choices: Gilead licenses to Medicines Patent Pool (IP Watch) (KEI) Global biotechnology IP evaluation by Scientific American (BIOtechNOW) The Bucknell book – ‘Pharmaceutical, Biotechnology and Chemical Inventions: World Protection and Exploitation’ (The SPC Blog) Dr Reddy’s finds… [read post]
20 Nov 2011, 9:39 pm
c and Cultural Organization (UNESCO)", any more than they should need to know the boiling point of a blogger's temperature. [read post]
